NYSE: NXENexgen Energy Ltd Stock
$6.63-0.06 (-0.9%)
Updated Jun 13, 2025
NXE Price
$6.63
Fair Value Price
N/A
Market Cap
$3.77B
52 Week Low
$3.91
52 Week High
$8.96
P/E
-54.79x
P/B
4.79x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$65.19M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.42
Operating Cash Flow
-$11M
Beta
1.55
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
NXE Overview
NexGen Energy Ltd. engages in the acquisition, exploration, and development of uranium properties. The company is headquartered in Vancouver, British Columbia and currently employs 32 full-time employees. The firm owns a portfolio of prospective uranium exploration assets in the Athabasca Basin, Saskatchewan, Canada, including a interest in Rook I, location of the Arrow Deposit, the Bow discovery, the Harpoon discovery and the Arrow South.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NXE's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -8.02% per year. Learn More
Zen Rating Component Grades
D
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important NXE news, forecast changes, insider trades & much more!
NXE News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NXE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NXE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NXE is good value based on its book value relative to its share price (4.79x), compared to the US Uranium industry average (5.3x)
P/B vs Industry Valuation
NXE is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NXE due diligence checks available for Premium users.
Valuation
NXE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-54.79x
Industry
157.37x
Market
31.36x
NXE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.79x
Industry
5.3x
NXE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NXE's financial health
Profit margin
Revenue
$0.0
Net Income
-$35.4M
Profit Margin
0%
NXE's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$1.1B
Liabilities
$321.9M
Debt to equity
0.42
NXE's short-term liabilities ($329.14M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NXE's short-term assets ($319.90M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NXE's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NXE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$793.8k
Investing
-$23.8M
Financing
-$4.5M
NXE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
NXE vs Uranium Stocks
Nexgen Energy Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.